TrialScientific reports2022

A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia.

Nirmani Yasara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.